Aclaris Therapeutis (ACRS) PT Lowered to $34 at JMP Securities
JMP Securities analyst Donald Ellis lowered the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $34.00 (from $47.00) while maintaining a Market Outperform rating.
JMP Securities analyst Donald Ellis lowered the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $34.00 (from $47.00) while maintaining a Market Outperform rating.